{"product_id":"locate-bio-ltd-product-pipeline-analysis-2022-update","title":"Locate Bio Ltd - Product Pipeline Analysis, 2022 Update","description":"\u003cp\u003eSummary\u003c\/p\u003e\n\n\u003cp\u003eLocate Bio Ltd (Locate Therapeutics), formerly RegenTec Ltd is a regenerative medicine development company that concentrates on clinical problems. Its lead products include orthopaedic matrices and offers regenerative medicine platform such as TAOS Technology. The company's TAOS specializes in tissue repair and enables the efficacy and safety enhancements for cell therapies. Locate Bio Ltd offers clinical treatments throughout the body including orthopedic medicine, cell therapy, drug delivery, cell culture and veterinary medicine. The company promotes activities of receptor-binding moieties, locally-applied drugs and emergent biological and cell-based therapies. It serves pharmaceutical and biopharmaceutical companies. Locate Bio Ltd is headquartered in Beeston, the UK.\u003c\/p\u003e\n\n\u003cp\u003eThis report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.\u003c\/p\u003e  \n\n\u003cp\u003eThe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.\u003c\/p\u003e\n\n\u003cp\u003eScope:The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developmentsThe report analyzes all pipeline products in development for the company Locate Bio LtdThe report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch dateThe report provides detailed description of products in development, technical specification and functionsThe report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.Reasons to Buy:Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapeDesign and develop your product development, marketing and sales strategies by understanding the competitor portfolioTo formulate effective Research \u0026amp; Development strategiesDevelop market-entry and market expansion strategiesExploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust returnPlan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etcIdentify, understand and capitalize the next high-value products that your competitor would add in its portfolioNote: Some sections may be missing if data is unavailable for the company\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 20 Pages \/ MCW16227406","offer_id":47645956047154,"sku":null,"price":900.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/locate-bio-ltd-product-pipeline-analysis-2022-update","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}